The Latest Cardiac and Vascular News
Senior Financial Leader is Company’s Second C-Level Hire in 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that David J. Tucker has joined the company as chief financial officer. He will direct the company’s financial strategies and […]
Renowned Stanford Cardiologist Brings Deep Clinical, Research, and Industry Expertise to Executive Team SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, today announced the appointment of Peter J. Fitzgerald, MD, PhD, […]
Multi-year strategic research and commercial collaboration agreement aims to significantly impact preventative care and underscores Company’s commitment to women’s health NASHUA, N.H., Oct. 11, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a new development and commercial collaboration […]
Accomplished surgeons will provide expert guidance on Medcura’s clinical, technical and market development. RIVERDALE, Md., Oct. 11, 2022 /PRNewswire/ — Seven top cardiothoracic, general, trauma, veterinary, and neurosurgeons will lead commercial-stage life science and medical device company Medcura Inc.’s new Surgical Scientific Advisory Board guiding the development and commercialization of its platform of surgical hemostats. […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its third quarter 2022 financial results on Tuesday, November 1, 2022. AtriCure will host an audio webcast at […]
NEW DELHI, Oct. 10, 2022 /PRNewswire/ — Translumina – a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products – appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the company’s Europe operations. Indranil is a veteran in the healthcare industry. In his most recent role […]
Funds to be used to facilitate U.S. commercial launch of FUROSCIX® BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, […]
DOVER, Del.–(BUSINESS WIRE)–Mana Capital Acquisition Corp. (“Mana Capital”) (Nasdaq: MAAQU; MAAQ; MAAQW; MAAQR), a publicly traded special purpose acquisition company, today announced that its registration statement on Form S-4, relating to the previously announced business combination between Mana Capital and Cardio Diagnostics, Inc. (“Cardio”), a pioneering precision cardiovascular testing company, […]
PRINCETON, N.J., Oct. 7, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced today that its Chief Financial Officer, Kathleen P. Bloch, MBA, CPA, plans to retire on March 31, 2023 at age 68, […]
IRVINE, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its third quarter 2022 financial results on Wednesday, […]
